Sopharma has agreed to acquire Pharmanova, a Serbian-based pharmaceutical company
Sopharma has signed a contract for the phased acquisition of the Serbian-based pharmaceutical manufacturer Pharmanova. The deal is structured in three steps, starting with the acquisition of 25% interest in December 2023, which is increased to 75% in 2024 and to 100% in 2025. With this transaction, Sopharma will further strengthen its market position in the Balkans and add to its family of businesses one of the biggest producers of branded herbal medicines and dietary products in Serbia.
Sopharma is a leading producer and distributor of healthcare products in the CEE region, with a vertically integrated business model running through the whole value chain, having its own R&D, manufacturing, and wholesale and retail distribution. The company is present in 33 countries and has a product portfolio of more than 200 products.
Founded in 1991, Pharmanova manufactures generic and over-the-counter drugs, dietary supplements, ointments and medical devices. It serves the markets of Serbia, Bosnia and Herzegovina, Montenegro and North Macedonia.
Oaklins’ team in Bulgaria acted as the buy-side advisor to Sopharma, leading the transaction process, deal structuring and negotiations, and assisting throughout the course of the acquisition.
联系交易团队
相关交易
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
更多信息Creo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
更多信息HD Clinical Ltd. has been acquired by NEXUS AG
NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.
更多信息